Cemre Robinson, MD Email Cemre Robinson
- ASSISTANT PROFESSOR | Pediatrics, Endocrinology - Adrenal Steroid Disorders
- ASSISTANT PROFESSOR | Medicine
- Pediatric Endocrinology
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Queens
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- Pediatric Bone Health Clinic 212-241-8210 212-241-8210
Cemre Robinson, MD is an Assistant Professor of the Adrenal Steroid Disorders Program in the Division of Pediatric Endocrinology and Diabetes in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis Children's Hospital. She received her medical degree from the Mercer University School of Medicine in Georgia and completed her pediatric residency at the Lewis M. Fraad Department of Pediatrics, Albert Einstein College of Medicine at Jacobi Medical Center in New York. Dr. Robinson completed her fellowship training in Pediatric Endocrinology at the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health in Bethesda, Maryland. Prior to joining Mount Sinai, she was an Assistant Professor of Pediatrics in the Section of Endocrinology at Yale School of Medicine. Her clinical and research work focused on the area of metabolic bone diseases as a recipient of an institutional K12 NIH grant. Dr. Robinson’s clinical focus is pediatric metabolic bone diseases, and growing expertise in the adrenal steroid disorders under the mentorship of Dr. Maria New.
Dr. Robinson’s expertise is in metabolic bone diseases. She is seeing patients in the weekly Pediatric Bone Health Clinic and cares for children and adolescents with:
• Vitamin D disorders
• Disorders of calcium and phosphorus metabolism
• Hypophosphatasia (HPP)
• Osteogenesis imperfecta (OI)
• Hypophosphatemic rickets (XLH)
• Fibrous dysplasia/McCune-Albright Syndrome (FD/MAS)
• Skeletal dysplasias
The purpose of the Pediatric Bone Health Clinic is to provide comprehensive care to infants, children, and adolescents regarding their bone health. Childhood is a critical time for attainment of bone mass, which impacts lifelong skeletal health. For children with rare bone diseases such as bone fragility or heritable forms of rickets, early diagnosis and treatment are necessary to ensure proper bone health. Children can also be at risk for developing low bone mass, osteoporosis and multiple fractures due to an underlying chronic disease. Early identification of the risk factors and prevention of osteoporosis through modifications in nutrition, physical activity, calcium and vitamin D intake are key to optimize bone health in children. Dr. Robinson offers individualized assessment and care-plans for each patient, including:
• Clinical evaluation for screening and diagnosis of metabolic bone disorders
• Laboratory evaluation of bone minerals, such as calcium and phosphorus and vitamin D metabolites
• Dual-energy X-ray absorptiometry (DXA) scans to measure bone mineral density
• Genetic testing for rare bone and mineral disorders such as osteogenesis imperfecta, hypophosphatemic rickets and hypophosphatasia
• Treatment as indicated, including Bisphosphonate infusions
For Referring Providers:
To refer a patient to Pediatric Bone Health Clinic, please call 212-241-8210, or fax the referral form to 212-241-5405.
- Vitamin D Deficiency
MD, Mercer University School of Medicine
Fellowship, Pedias Endocrinology
National Institute of Health
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Robinson during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Ultragenyx Pharmaceutical Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.